Tag Archives: patients

FDA Approves Bylvay (odevixibat) for the Treatment of Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis (PFIC)

FDA Approves Bylvay (odevixibat) for the Treatment of Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis (PFIC) BOSTON, July 20, 2021 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, today announced U.S. Food & Drug Administration (FDA) approval of Bylvay (odevixibat), the first drug approved for the treatment of pruritus in… Read More »

Fasting diet for ms patients

Contact us Submission enquiries: Access here and click Contact Us General enquiries: info biomedcentral. With the fasting-induced shift from glucose to fat oxidation—as is observed during fasting or carbohydrate restriction —AMPK stimulation may repress inflammatory responses, such as those present in conditions like MS or in chronic lifestyle diseases like diabetes and obesity. In addition,… Read More »